Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
122 INR | -0.77% |
|
-6.58% | +47.94% |
05-28 | Crestchem Limited Recommends Final Maiden Dividend for the Financial Year Ended March 31, 2024 | CI |
05-28 | Crestchem Limited Reports Earnings Results for the Full Year Ended March 31, 2024 | CI |
Valuation
Fiscal Period: March | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Capitalization 1 | 37.5 | 44.25 | 33 | 78.6 | 123 | 367.3 |
Enterprise Value (EV) 1 | 35.73 | 44.09 | 26.77 | 75.13 | 125.6 | 358.6 |
P/E ratio | -19.4 x | -26.1 x | 7.44 x | 13.7 x | 21.7 x | 53 x |
Yield | - | - | - | - | - | - |
Capitalization / Revenue | 72.3 x | 42.4 x | 0.53 x | 1.03 x | 1.55 x | 2.2 x |
EV / Revenue | 68.9 x | 42.2 x | 0.43 x | 0.98 x | 1.58 x | 2.14 x |
EV / EBITDA | -14.5 x | -26.1 x | 4.71 x | 11.4 x | 16.8 x | 43.3 x |
EV / FCF | -13.4 x | -37.3 x | 5.65 x | -16.2 x | 10.9 x | 15 x |
FCF Yield | -7.45% | -2.68% | 17.7% | -6.16% | 9.21% | 6.65% |
Price to Book | 5.82 x | 9.32 x | 3.59 x | 5.27 x | 5.97 x | 13.3 x |
Nbr of stocks (in thousands) | 3,000 | 3,000 | 3,000 | 3,000 | 3,000 | 3,000 |
Reference price 2 | 12.50 | 14.75 | 11.00 | 26.20 | 41.00 | 122.4 |
Announcement Date | 8/19/18 | 8/28/19 | 11/28/20 | 8/27/21 | 7/28/22 | 7/29/23 |
Income Statement Evolution (Annual data)
Fiscal Period: March | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net sales 1 | 0.519 | 1.044 | 62.04 | 76.42 | 79.47 | 167.3 |
EBITDA 1 | -2.47 | -1.687 | 5.69 | 6.588 | 7.473 | 8.275 |
EBIT 1 | -2.5 | -1.797 | 5.495 | 6.352 | 7.216 | 8.057 |
Operating Margin | -481.75% | -172.1% | 8.86% | 8.31% | 9.08% | 4.82% |
Earnings before Tax (EBT) 1 | -2.245 | -1.656 | 5.696 | 6.733 | 7.812 | 9.382 |
Net income 1 | -1.936 | -1.696 | 4.438 | 5.741 | 5.672 | 6.935 |
Net margin | -373.09% | -162.5% | 7.15% | 7.51% | 7.14% | 4.15% |
EPS 2 | -0.6454 | -0.5655 | 1.479 | 1.914 | 1.891 | 2.312 |
Free Cash Flow 1 | -2.662 | -1.183 | 4.735 | -4.63 | 11.56 | 23.84 |
FCF margin | -512.99% | -113.36% | 7.63% | -6.06% | 14.55% | 14.25% |
FCF Conversion (EBITDA) | - | - | 83.22% | - | 154.7% | 288.17% |
FCF Conversion (Net income) | - | - | 106.69% | - | 203.82% | 343.85% |
Dividend per Share | - | - | - | - | - | - |
Announcement Date | 8/19/18 | 8/28/19 | 11/28/20 | 8/27/21 | 7/28/22 | 7/29/23 |
Balance Sheet Analysis
Fiscal Period: March | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net Debt 1 | - | - | - | - | 2.57 | - |
Net Cash position 1 | 1.77 | 0.16 | 6.23 | 3.47 | - | 8.69 |
Leverage (Debt/EBITDA) | - | - | - | - | 0.3444 x | - |
Free Cash Flow 1 | -2.66 | -1.18 | 4.74 | -4.63 | 11.6 | 23.8 |
ROE (net income / shareholders' equity) | -26.1% | -30.3% | 63.7% | 47.6% | 31.9% | 28.8% |
ROA (Net income/ Total Assets) | -13.5% | -13.2% | 34.1% | 15% | 14.3% | 12.5% |
Assets 1 | 14.29 | 12.88 | 13 | 38.24 | 39.56 | 55.64 |
Book Value Per Share 2 | 2.150 | 1.580 | 3.060 | 4.970 | 6.870 | 9.180 |
Cash Flow per Share 2 | 0.3000 | 0.2300 | 0.1600 | 0.1200 | 0.0300 | 2.900 |
Capex 1 | 1.11 | 0.18 | 0.05 | 0.59 | 0 | 0.16 |
Capex / Sales | 213.35% | 16.95% | 0.09% | 0.77% | 0.01% | 0.1% |
Announcement Date | 8/19/18 | 8/28/19 | 11/28/20 | 8/27/21 | 7/28/22 | 7/29/23 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
+47.94% | 4.42M | |
+16.57% | 8.36B | |
+3.08% | 7.69B | |
-22.01% | 4.6B | |
-9.60% | 3.58B | |
-19.14% | 3.22B | |
-6.31% | 1.28B | |
-26.93% | 1.11B | |
-7.66% | 887M | |
-16.16% | 856M |
- Stock Market
- Equities
- CRSTCHM Stock
- Financials Crestchem Limited